Assessment of the Role of EGF +61a/G and EGFR R497K Polymorphism in Patients With Inflammatory Bowel Disease: A Case-Control Study

ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE

doi 10.25000/acem.416704